- Filed
- Nov 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 8, 2024 | 1.3B sh |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $53.25M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $40.79M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $2.94M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $2.13M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $59.56M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $45.2M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $93.56M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $74.92M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $5.19M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $4.13M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $29.32M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $27.87M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 1.13M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 1.11M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $3.02M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$36.68M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | −$70.06M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$61.03M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$128.1M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.02 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$0.05 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.02 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$0.05 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $7.03M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $21.58M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $7.2M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $20.28M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$23.52M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$48.62M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$13.83M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$40.37M |
| Revenue | Q3 2024 · Sep 30, 2023 | $406K |
| Revenue | Q3 2024 · Sep 30, 2023 | $1.49M |